ReviewNuclear medicine and molecular imaging2026

Current Status of PSMA-Targeted Agents Based on Small Molecules for Prostate Cancer in Preclinical Studies.

Ayman Muzammal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.